|
US2019209600A1
|
|
Compositions and methods for cholesterol, glucose and microbiome control
|
|
EP3609503A1
|
|
Production of aspirin-triggered resolvins without the use of aspirin in a dietary omega-3 supplement
|
|
US2018185427A1
|
|
Cassytha filiformis and/or cuscuta sandwichiana administered orally to induce sleep
|
|
SG10201800029TA
|
|
An additive proportioning system
|
|
US2018036279A1
|
|
Multivitamin capable of beneficial gene regulation through microRNA (miRNA)
|
|
US2017173047A1
|
|
Device and method of using volatile organic compounds that affect mood, emotion or a physiologic state
|
